Results 21 to 30 of about 36,244 (312)
Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular disease, which has been reported with covid infection as well as covid vaccines, particularly AstraZeneca and Janssen vaccines.
Sajid Hameed +2 more
exaly +1 more source
Evaluation of Antibody Response in Patients with Cancer Following Sinopharm Covid-19 Vaccine in 2021 [PDF]
Background and purpose: COVID-19 is one of the biggest pathogens that mainly targets the human respiratory system. Among the preventive methods against contracting COVID-19, vaccination has had an important effect in preventing COVID-19 and is an ...
Mohammad Eslamijouybari +4 more
doaj +1 more source
The risk of cardiovascular diseases is closely related to diabetes. Macrovascular disease is the main cause of death and disability in patients with type 2 diabetes.
Rui Song +12 more
doaj +1 more source
Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes
Type 2 diabetes mellitus (T2DM) is a chronic progressive metabolic disease that has become a growing health problem worldwide, and the dangers of hyperglycemia and its chronic complications have long been considered a goal of diabetes treatment.
Zijun Ma +4 more
doaj +1 more source
Correction: Unexpected hypereosinophilia after sinopharm vaccination: a case report
Behnam Dalfardi +5 more
openaire +3 more sources
The rising need for repeated booster vaccinations against SARS-CoV-2 infections raises the question of whether chronic immunosuppressive chemotherapies influence the efficacy of vaccination. Here, we present the case of a 70-year-old post-thymoma surgery
Akos Koller, János Szebeni
doaj +1 more source
Post COVID-19 vaccination Guillain-Barre syndrome: three cases
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of patients, it is preceded by an upper respiratory or gastrointestinal tract infection.
Seyedehnarges Tabatabaee +6 more
doaj +1 more source
Safety of sinopharm COVID-19 vaccine in children and adolescents aged 5 to 18 years: a cohort event monitoring study. [PDF]
Although the safety of the BBIBP-CorV (Sinopharm) vaccine has been confirmed in both adults and children, safety data remain limited for individuals under 18 years of age.
Emamian MH +13 more
europepmc +2 more sources
Vaccine Induced Immune Thrombotic Thrombocytopenia After Sinopharm Vaccination: A Systematic Review of Case Reports. [PDF]
Vaccine‐induced thrombotic thrombocytopenia (VITT) has been linked to vector‐based vaccines, but only four cases following whole‐virus vaccines (Sinopharm) have been reported, as far as we are aware.
Rehman S +5 more
europepmc +2 more sources
Background: Due to increased vaccination rates and the continued spread of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus, many people are developing “hybrid immunity” to the virus.
Rawaq Taleb Hassan, Suhad Hadi Mohammed
doaj +1 more source

